Skip to main content
Clinical Trials/ISRCTN23657907
ISRCTN23657907
Active, not recruiting
未知

A multi-centre randomised controlled trial of the clinical and cost-effectiveness of pre-hospital whole blood administration versus standard care for traumatic haemorrhage

HS Blood and Transplant0 sites848 target enrollmentDecember 7, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
Traumatic haemorrhage
Sponsor
HS Blood and Transplant
Enrollment
848
Status
Active, not recruiting
Last Updated
2 years ago

Overview

Brief Summary

2023 Protocol article in https://pubmed.ncbi.nlm.nih.gov/37964393/ RCT protocol (added 16/11/2023) 2024 Protocol article in https://pubmed.ncbi.nlm.nih.gov/38316586/ Implementation study protocol (added 06/02/2024)

Registry
who.int
Start Date
December 7, 2022
End Date
June 1, 2025
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
HS Blood and Transplant

Eligibility Criteria

Inclusion Criteria

  • 1\. Patient (of any age) who has suffered a traumatic injury
  • 2\. Attended by a participating Air Ambulance Service (AAS) clinical team
  • 3\. Requires pre\-hospital blood transfusion to treat major traumatic haemorrhage

Exclusion Criteria

  • 1\. No intravenous or intraosseous access
  • 2\. Knowledge that the patient will object to being given blood transfusion for any reasons
  • 3\. Blood already administered on\-scene, prior to the arrival of the participating Air Ambulance team

Outcomes

Primary Outcomes

Not specified

Similar Trials